Search Results - "Shirakami, Yohei"

Refine Results
  1. 1

    Possible Mechanisms of Green Tea and Its Constituents against Cancer by Shirakami, Yohei, Shimizu, Masahito

    Published in Molecules (Basel, Switzerland) (07-09-2018)
    “…A number of epidemiological, clinical, and experimental researches have indicated that administration of green tea appears to have anti-cancer activity…”
    Get full text
    Journal Article
  2. 2

    MicroRNA as a Biomarker in Gastroenterological Cancers by Morishita, Asahiro, Shirakami, Yohei, Okumura, Tomoyuki, Masaki, Tsutomu

    “…This Special Issue aims to highlight the usefulness of microRNA (miRNA) as diagnostic and prognostic markers of gastroenterological cancer (GC) [...]…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Hepatic metabolism of retinoids and disease associations by Shirakami, Yohei, Lee, Seung-Ah, Clugston, Robin D., Blaner, William S.

    Published in Biochimica et biophysica acta (01-01-2012)
    “…The liver is the most important tissue site in the body for uptake of postprandial retinoid, as well as for retinoid storage. Within the liver, both…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Cancer chemoprevention with green tea catechins: from bench to bed by Shirakami, Yohei, Shimizu, Masahito, Moriwaki, Hisataka

    Published in Current drug targets (01-12-2012)
    “…Many epidemiological studies and a large number of experimental studies using a variety of animal models have observed that consumption or administration of…”
    Get more information
    Journal Article
  7. 7

    The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice by Ideta, Takayasu, Shirakami, Yohei, Miyazaki, Tsuneyuki, Kochi, Takahiro, Sakai, Hiroyasu, Moriwaki, Hisataka, Shimizu, Masahito

    “…Non-alcoholic fatty liver disease (NAFLD), which is strongly associated with metabolic syndrome, is increasingly a major cause of hepatic disorder. Dipeptidyl…”
    Get full text
    Journal Article
  8. 8

    High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model by Taguchi, Daisuke, Shirakami, Yohei, Sakai, Hiroyasu, Maeda, Toshihide, Miwa, Takao, Kubota, Masaya, Imai, Kenji, Ibuka, Takashi, Shimizu, Masahito

    Published in Nutrients (01-08-2024)
    “…More effective treatments for hepatitis viral infections have led to a reduction in the incidence of liver cirrhosis. A high-fat diet can lead to chronic…”
    Get full text
    Journal Article
  9. 9

    Inhibitory effects of a selective prostaglandin E2 receptor antagonist RQ-15986 on inflammation-related colon tumorigenesis in APC-mutant rats by Shirakami, Yohei, Nakanishi, Takayuki, Ozawa, Noritaka, Ideta, Takayasu, Kochi, Takahiro, Kubota, Masaya, Sakai, Hiroyasu, Ibuka, Takashi, Tanaka, Takuji, Shimizu, Masahito

    Published in PloS one (18-05-2021)
    “…Prostaglandin E2 receptor EP4 is involved in inflammation and related tumorigenesis in the colorectum. This study aimed to investigate the chemopreventive…”
    Get full text
    Journal Article
  10. 10

    Alpha-Glucosidase Inhibitor Voglibose Suppresses Azoxymethane-Induced Colonic Preneoplastic Lesions in Diabetic and Obese Mice by Kato, Junichi, Shirakami, Yohei, Mizutani, Taku, Kubota, Masaya, Sakai, Hiroyasu, Ibuka, Takashi, Shimizu, Masahito

    “…Type 2 diabetes mellitus and its related insulin resistance are known to increase the risk of cancer. Anti-diabetic agents can improve insulin resistance and…”
    Get full text
    Journal Article
  11. 11

    Animal naming test stratifies the risk of falls and fall-related fractures in patients with cirrhosis by Miwa, Takao, Hanai, Tatsunori, Hirata, Sachiyo, Nishimura, Kayoko, Unome, Shinji, Nakahata, Yuki, Imai, Kenji, Shirakami, Yohei, Suetsugu, Atsushi, Takai, Koji, Shimizu, Masahito

    Published in Scientific reports (21-02-2024)
    “…This study aimed to determine the relationship between animal naming test (ANT), falls, and fall-related fractures in patients with cirrhosis. Cognitive…”
    Get full text
    Journal Article
  12. 12

    Preventive effects of the sodium glucose cotransporter 2 inhibitor tofogliflozin on diethylnitrosamine-induced liver tumorigenesis in obese and diabetic mice by Obara, Koki, Shirakami, Yohei, Maruta, Akinori, Ideta, Takayasu, Miyazaki, Tsuneyuki, Kochi, Takahiro, Sakai, Hiroyasu, Tanaka, Takuji, Seishima, Mitsuru, Shimizu, Masahito

    Published in Oncotarget (29-08-2017)
    “…Sodium glucose cotransporter 2 inhibitors are expected to ameliorate the abnormalities associated with metabolic syndrome including non-alcoholic fatty liver…”
    Get full text
    Journal Article
  13. 13

    Editorial: Cancer and nutrients: new chemicals, signals, and biomarker-based therapy by Qin, Xian-Yang, Mendoza-Parra, Marco Antonio, Shirakami, Yohei

    Published in Frontiers in oncology (11-04-2023)
    “…Editorial on the Research Topic Cancer and nutrients: new chemicals, signals, and biomarker-based therapy Nutrients such as vitamins, minerals, fats, and amino…”
    Get full text
    Journal Article
  14. 14

    A Novel Mouse Model of Intrahepatic Cholangiocarcinoma Induced by Azoxymethane by Shirakami, Yohei, Kato, Junichi, Ohnishi, Masaya, Taguchi, Daisuke, Maeda, Toshihide, Ideta, Takayasu, Kubota, Masaya, Sakai, Hiroyasu, Tomita, Hiroyuki, Tanaka, Takuji, Shimizu, Masahito

    “…Cholangiocarcinoma is the second most common primary cancer of the liver and has a poor prognosis. Various animal models, including carcinogen-induced and…”
    Get full text
    Journal Article
  15. 15

    Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor tofogliflozin on colorectal tumorigenesis in diabetic and obese mice by Kato, Junichi, Shirakami, Yohei, Ohnishi, Masaya, Mizutani, Taku, Kubota, Masaya, Sakai, Hiroyasu, Ibuka, Takashi, Tanaka, Takuji, Shimizu, Masahito

    Published in Oncology reports (01-12-2019)
    “…Sodium‑glucose cotransporter 2 inhibitors were developed for the treatment of diabetes mellitus. Although recent studies have indicated that sodium‑glucose…”
    Get full text
    Journal Article
  16. 16

    Pitavastatin inhibits azoxymethane‐induced colonic preneoplastic lesions in C57BL/KsJ‐db/db obese mice by Yasuda, Yoichi, Shimizu, Masahito, Shirakami, Yohei, Sakai, Hiroyasu, Kubota, Masaya, Hata, Kazuya, Hirose, Yoshinobu, Tsurumi, Hisashi, Tanaka, Takuji, Moriwaki, Hisataka

    Published in Cancer science (01-07-2010)
    “…Obesity and related metabolic abnormalities are risk factors for colorectal cancer. A state of chronic inflammation and adipocytokine imbalance may play a role…”
    Get full text
    Journal Article
  17. 17

    Dietary supplementation with branched‐chain amino acids suppresses diethylnitrosamine‐induced liver tumorigenesis in obese and diabetic C57BL/KsJ‐db/db mice by Iwasa, Junpei, Shimizu, Masahito, Shiraki, Makoto, Shirakami, Yohei, Sakai, Hiroyasu, Terakura, Yoichi, Takai, Koji, Tsurumi, Hisashi, Tanaka, Takuji, Moriwaki, Hisataka

    Published in Cancer science (01-02-2010)
    “…Obesity and related metabolic abnormalities, including insulin resistance, are risk factors for hepatocellular carcinoma in non‐alcoholic steatohepatitis as…”
    Get full text
    Journal Article
  18. 18

    Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: Suppressing effects of EGCG on the development of liver lesions by Kochi, Takahiro, Shimizu, Masahito, Terakura, Daishi, Baba, Atsushi, Ohno, Tomohiko, Kubota, Masaya, Shirakami, Yohei, Tsurumi, Hisashi, Tanaka, Takuji, Moriwaki, Hisataka

    Published in Cancer letters (01-01-2014)
    “…Highlights • We examined the effects of EGCG on the hepatotumorigenesis in SHRSP-ZF rats treated with HFD and CCl4. • SHRSP-ZF rats presented with features of…”
    Get full text
    Journal Article
  19. 19

    Prevention of Colorectal Cancer by Targeting Obesity-Related Disorders and Inflammation by Shirakami, Yohei, Ohnishi, Masaya, Sakai, Hiroyasu, Tanaka, Takuji, Shimizu, Masahito

    “…Colorectal cancer is a major healthcare concern worldwide. Many experimental and clinical studies have been conducted to date to discover agents that help in…”
    Get full text
    Journal Article
  20. 20

    Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG by Shimizu, Masahito, Shirakami, Yohei, Moriwaki, Hisataka

    “…Tea is one of the most popular beverages consumed worldwide. Epidemiologic studies show an inverse relationship between consumption of tea, especially green…”
    Get full text
    Journal Article Book Review